Varex Imaging Corporation (VREX)

Vertex Pharmaceuticals has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Verisk Analytics has underperformed the broader market over the past year, and analysts remain moderately optimistic about the stock’s prospects.

VREX has a P/S ratio of 0.47. This compares to its industry's average P/S of 1.4. These are just a handful of the figures considered in VAREX IMAGING's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings ...

What Are Wall Street Analysts' Target Price for Vertex Pharmaceuticals Stock?

See the latest Varex Imaging Corp stock price (VREX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.